Improved Patient Outcome

Pharmacogenetics (PGx) is the well established science focused on how an individual metabolizes medications. This is necessary for most of the Patients. It increases safety and efficacy of Prescription Drug Therapy.

Complete Integration Support Team

From credentialing and billing to marketing, we have your complete solution. Those are the tools necessary to succeed. Ask your regional representative about our in-office support materials!

Become part of the revolution

Bring Pharmacogenetic Testing into your daily patient interaction: Increasing the efficacy of medications, decreasing the potential for ADRs and reducing the number of prescribed medications.

Personalized Medicine

Means Improved Patent Outcomes.

MedXPrime Pharmacogenetic Testing Clinical Integration

“Right Information, Right Drug, Right Dose, Right from the beginning.”

The era of ‘Personalized Medicine’ has now arrived. It allows your physician to understand from your specific DNA profile what medications will work best. It’s called ‘pharmacogenetic testing’ or PGx.
No more trial and error prescribing, no longer having the danger of Adverse Drug Reactions (ADRs) which put over 2 million people annually in the hospital and cause over 125,000 deaths each year.
Now doctors can have the knowledge to avoid these issues. Personalized Medicine helps doctors to individualize drug therapy, decrease adverse drug reactions, and increase the effectiveness of treatment plans.

The MedXPrime Mission is to reach

Every Doctor - Every Patient.

What Physicians are saying

“Pharmacogenomics holds great promise to shed scientific light on the often risky and costly process of drug development, and to provide greater confidence about the risks and benefits of drugs in specific populations. Pharmacogenomics is a new field, but we intend to do all we can to use it to promote the development of medicines. By providing practical guidance on how to turn the explosion of pharmacogenomic information into real evidence on new drugs, we are taking an important step toward that goal.”

Mark B. McClellan, M.D., Ph.D., FDA
Commissioner. On the issuance of “Draft Guidance for Industry: Pharmacogenomic Data Submissions.”

“Without (Pharmacogenetics) testing, neither you nor your doctor knows exactly how you’ll react to the medication. It may not work for you, or you may have serious side effects such as bleeding. You might have to try different doses — or even different medications — before finding a treatment that works for you.
Pharmacogenomics speeds up that process. Before you take a single dose of medication, you can have a test to see how you’re likely to respond to the medication. “

Mayo Clinic
On Pharmacogenetics

“The current gap between current practice and that which will soon be enabled by new personalized medicine technologies could arguably mean the difference between life and death for thousands of patients per year. Physicians are likely to be hauled into court and called to account for this discrepancy unless steps are taken to provide physicians with better education and guidelines to integrate the new data and technologies into their clinical practice. The window of opportunity to act is short. Once the litigation snowball starts to roll, it will quickly become unstoppable.”

Gary E Marchant, Doug E Campos-Outcalt, Rachel A Lindor, Personalized Medicine. 2011;8(4):457-467.


WordPress Image Lightbox Plugin